Leramistat (HMC-C-01-A, MBS2320) is a mitochondrial complex 1 inhibitor, involving in cell metabolism immune metabolism regulation. Leramistat also inhibits ATP production in Thp1 human monocytes (IC50: 0.63 µM). Leramistat inhibits atopic dermatitis and other skin diseases autoimmune diseases, inflammatory diseases, cancer, and also inhibits osteoclast mediated disease[1][2][3].
Molecular Weight:
404.91
Purity:
98.00
CAS Number:
[1642602-54-7]
Formula:
C20H21ClN2O3S
Target:
Mitochondrial Metabolism
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted